Medically reviewed by Drugs.com. Last updated on Mar 30, 2020.
Applies to the following strengths: 250 mcg; 500 mcg
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance
Initial dose: 250 mcg orally once a day for 4 weeks
Maintenance dose: 500 mcg orally once a day
-Starting the dose at 250 mcg daily may reduce the rate of treatment discontinuation, but it is not the effective/therapeutic dose.
-This drug is not a bronchodilator and is not indicated for acute exacerbation treatment.
Use(s): To reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.
Renal Dose Adjustments
No adjustment recommended.
Liver Dose Adjustments
Contraindicated in moderate to severe liver impairment (Child-Pugh B or C)
-Consider the risk to benefit of administering to patients with mild renal impairment (Child-Pugh A).
-Moderate to severe liver impairment (Child-Pugh B or C)
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Data not available
-Monitor weight regularly.
-Advise patients and caregivers to watch for emergence or worsening of insomnia, anxiety, depression, suicidal thoughts, or other mood changes and to contact their healthcare provider if such changes occur.
More about roflumilast
- Side Effects
- During Pregnancy
- Imprints, Shape & Color Data
- Drug Interactions
- En Español
- 56 Reviews
- Drug class: selective phosphodiesterase-4 inhibitors
Other brands: Daliresp